Key arguments in support of the idea. ▪ UNH stock has come under pressure from a series of adverse events, though Q1 earnings may improve investor sentiment regarding further UNH business growth potential. ▪ A good moment for buying, both fundamentally and technically. Investment Thesis UnitedHealth Group (UNH) engages in the provision of health...
Entry at 64to 66 Target 90Rs This counter can easily reach at 90 Rs within 6 months. Good level to invest
I stand before you to discuss the transformative power of e-education and its pivotal role in shaping the future of learning. As we navigate the dynamic landscape of education, e-learning emerges as a beacon of innovation, offering unprecedented opportunities for learners across the globe. In this digital era, e-education transcends geographical boundaries,...
Bank of Baroda breakout confirmed. Keep strict stoploss.
Dear Esteemed Investors, Everyone asked me to write an analytics on CARR. Although my forecasts achieved some success with this stock, let me remind you it's only a very small percentage of my portfolio. I can measure my exposure in hundreds of thousands, which is relatively small compared to my gold exposure, which I measure in millions. With that, I care about...
TEXRAIL turned out to be a Multi-bagger in 2023. The initial call was given at 64 for a target of 116, 136, 157. It blasted all 3 targets in less than 8 months resulting in a profit of more than 2.75x - Amazing Isn't it Recently the Indian Govt has announced major investment of more than 1 Lakh Crores into Railways & Infrastructure and among the Railway Themed...
Microsoft's trajectory into the future takes a compelling turn with the addition of Sam Altman, an AI luminary, to its internal team. This analysis explores the fusion of technology and finance, specifically delving into Altman's impact on AI development within Microsoft. We examine the integration of advanced AI features into Microsoft 365 and assess Microsoft's...
I must admit despite all the TA I have tried with this name, profit has eluded me because most upward action has bee around ER. I have tried not hold big positions into ER, but this name has proved me wrong last three times. Bounced off of 60 VMA nicely an caught fire. another test of 45 or flag above would set this up nicely for 60. despite sluggish...
Pfizer PFE announced that the FDA has granted approval to its oral, once-daily pill called etrasimod to treat moderately-to-severely active ulcerative colitis (UC). The oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator will be marketed by the brand name of Velsipity (2 mg dose). The approval for etrasimod was based on data from two...
TSLA has been compressing into a multi-year squeeze on the charts. Whether it's the global economy going into a rough patch, the uncertainty of the 2024 US presidential election, or multiple wars happening in the East there seem to be a lot of potential market forces possibly pushing high multiple stocks down for the near future. But Tesla as a company is on...
NYSE:BABA Based on the weekly ElliotWaves analysis , BABA is currently in a corrective wave structure. The corrective wave structure is a complex wave pattern that can take many different forms. However, the most common corrective wave structure is a three-wave ABC pattern. BABA appears to be in the wave B of the corrective wave structure. Wave B is a...
On 24 July, the NASDAQ 100 Index conducted a special rebalance to reduce the concentration of the so-called ‘magnificent seven’ in the index. The seven stocks whose strong performance this year has driven the index are Apple, Amazon, Microsoft, Alphabet, Tesla, Nvidia, and Meta. The index is typically reconstituted annually in December, with additional...
With a lot of attention ahead of its earnings report, NYSE:QS had a volatile reaction to the report yesterday, but it is one of several companies vying for dominance in Solid State Battery technology. Auto parts are a niche sub-industry of Electric Vehicles to pay attention to for both short term and long term. From the weekly chart: The stock is building a...
Rev Growth YoY and FWD are 50 and 23% respectively and 307 and 167% above the sector respectively while PE GAAP TTM and FWD are 71 and 65% below sector! This implies a huge discount in growth. Gross Profit does lag behind the sector by about 12%, but the valuation combined with the outsized growth substantially off-sets this disparity. On a technical note,...
COHR caught my attention for a few reasons. 1st. It is ≈11% of total holding of Scion Asset Mngt holdings, one of the best performing funds since 2008. 2. Technical: SP trading in demand zone, appearing to possibly be in process of forming a double bottom- confirmed on 3 day rule, vol, etc. passing 46.46 area. 3. Valuation: Currently at steep discount to...
Morning*'s valuation implies 2024 EV/Sales multiple of 5.5x. Forecasted Revenue growth 24% annualized rate over next five years! TTM Rev Growth YoY was 43%; 206% above sector median! Rev FWD growth is 26% or 142% above sector median. Expected to become profitable on adjusted OpMargin basis next year and GAAP profitable in 2027 in line with current models as long...
Hi! Right now, MEX is considered by many people in the Elrond space as "garbage", but I personally consider it an unpolished diamond. At the time of posting, its market capitalization is nearly $ 23million. With the release of the card in Q3-Q4, there will be more and more transactions that will put the burn in function. At the time of posting, there are...
The slight gross margin decrease of 4.8% was enough to resume the HS pattern on the chart executing a normal pullback- relative to the "neckline" where HS patterns are confirmed with some other criterion. Despite the quarterly margin contraction, expected cost reductions should start to materialize in 2024. Everything on the income statement is trending in the...